ScreenerHero

ZIVO ZIVO Bioscience, Inc.

NAS · US · Healthcare · Biotechnology · zivobioscience.com
3.190USD-9.12%Mkt Cap: 14.12M $P/E: —

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap14.12M USD
Enterprise Value16.71M USD
Revenue (TTM)209.03K USD
Gross Profit48.95K USD
Net Income (TTM)-13.38M USD
Revenue/Share0.06 USD
Last Price3.190 USD
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS98978N2009
Valuation
P/E (Trailing)—
P/E (Forward)-3.42
PEG—
EV/EBITDA—
EV/Revenue79.92
P/S82.68
P/B-4.78
EPS (TTM)-2.18
EPS (Forward)-1.20
52W Range
1.11011% of range19.65
52W High19.65 USD
52W Low1.110 USD
Profitability
Gross Margin31.14%
Oper. Margin-1551.76%
EBITDA Margin0.00%
Profit Margin-8513.44%
ROE2599.52%
ROA-814.60%
Growth
Revenue Growth108.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.31M USD
CapEx (TTM)—
FCF Margin-1252.12%
FCF Yield-18.53%
Net Debt762.47K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.49
Current Ratio0.08
Quick Ratio0.02
Book Value/Sh-0.86 USD
Cash/Share0.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:6
Split DateOct 27, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.4.22M
Float1.47M
Insiders47.30%
Institutions0.10%
Short Interest
Short Ratio5.4d
Short % Float4.02%
Short % Out.3.17%
Shares Short57.69K
Short (prev mo.)26.89K
Technical
SMA 503.859 (-17.3%)
SMA 2005.649 (-43.5%)
Beta0.39
S&P 52W Chg16.45%
Avg Vol (30d)427
Avg Vol (10d)680
Technical Indicators
RSI (14)41.2
MACD-0.1837
MACD Signal-0.1121
MACD Hist.-0.0716
BB Upper4.713 USD
BB Middle3.908 USD
BB Lower3.103 USD
BB Width41.21%
ATR (14)0.3701 USD
Vol Ratio (20d)2.02x